These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23509897)

  • 1. Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response.
    Lubega S; Agbim U; Surjadi M; Mahoney M; Khalili M
    Liver Int; 2013 Aug; 33(7):999-1007. PubMed ID: 23509897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formal patient education improves patient knowledge of hepatitis C in vulnerable populations.
    Surjadi M; Torruellas C; Ayala C; Yee HF; Khalili M
    Dig Dis Sci; 2011 Jan; 56(1):213-9. PubMed ID: 20972850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety.
    Nordstrom EM; Keniston A; Baouchi F; Martinez-Camacho A
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):10-16. PubMed ID: 27755117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How physicians describe outcomes to HCV therapy: prevalence and meaning of "cure" during provider-patient in-office discussions of HCV.
    Hamilton HE; Gordon C; Nelson M; Cotler SJ; Martin P
    J Clin Gastroenterol; 2008 Apr; 42(4):419-24. PubMed ID: 18277894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an Interdisciplinary Telehealth Model of Provider Training and Comprehensive Care for Hepatitis C and Opioid Use Disorder in a High-Burden Region.
    Sherbuk JE; Knick TK; Canan C; Ross P; Helbert B; Cantrell ES; Cantrell CJ; Stallings R; Barron N; Jordan D; McManus KA; Dillingham R
    J Infect Dis; 2020 Sep; 222(Suppl 5):S354-S364. PubMed ID: 32877562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shelter-Based Integrated Model Is Effective in Scaling Up Hepatitis C Testing and Treatment in Persons Experiencing Homelessness.
    Khalili M; Powell J; Park HH; Bush D; Naugle J; Ricco M; Magee C; Braimoh G; Zevin B; Fokuo JK; Masson CL
    Hepatol Commun; 2022 Jan; 6(1):50-64. PubMed ID: 34628726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proper patient education improves hepatitis C patients' disease-related knowledge and antiviral treatment acceptance in rural China].
    Yang M; Rao HY; Feng B; Wu E; Wei L; Lok AS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):824-828. PubMed ID: 30616316
    [No Abstract]   [Full Text] [Related]  

  • 8. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
    Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of provider type on hepatitis C outcomes with boceprevir-based and telaprevir-based regimens.
    Backus LI; Belperio PS; Shahoumian TA; Mole LA
    J Clin Gastroenterol; 2015 Apr; 49(4):329-35. PubMed ID: 24667591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge, Attitudes, and Behaviors Related to Hepatitis C Screening and Treatment among Health Care Providers in Washington, DC.
    Doshi RK; Ruben M; Drezner K; Lachmann A; Kuo I; Chanes-Mora P; Varga L; Saafir-Callaway B; Visconti A; Kharfen M
    J Community Health; 2020 Aug; 45(4):785-794. PubMed ID: 32125591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C Treatment Cascade in a Federally Qualified Health Center.
    Hachey DM; Holmes JT; Aubuchon-Endsley NL
    J Community Health; 2020 Apr; 45(2):264-268. PubMed ID: 31512110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide survey of specialist knowledge on current standard of care (Peg-IFN/RBV) and barriers of care in chronic hepatitis C patients in China.
    Wei L; Li J; Yang X; Wang G; Feng B; Hou J; Duan Z; Jia J; Ren H; Niu J; Chen X; Wang FS; Shang J; Bo Q; Li R; Liu Y; Zhuang H
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1995-2003. PubMed ID: 27043040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care.
    Burman BE; Mukhtar NA; Toy BC; Nguyen TT; Chen AH; Yu A; Berman P; Hammer H; Chan D; McCulloch CE; Khalili M
    Dig Dis Sci; 2014 Jan; 59(1):46-56. PubMed ID: 24052195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing patient and provider knowledge gaps: An evaluation of a community informed hepatitis C online course.
    Buller-Taylor T; McGuinness L; Yan M; Janjua NZ
    Patient Educ Couns; 2018 Jun; 101(6):1095-1102. PubMed ID: 29370951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors.
    Yamada G; Iino S; Okuno T; Omata M; Kiyosawa K; Kumada H; Hayashi N; Sakai T
    Clin Drug Investig; 2008; 28(1):9-16. PubMed ID: 18081356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving access to care by allowing self-referral to a hepatitis C clinic.
    Doucette KE; Robson V; Shafran S; Kunimoto D
    Can J Gastroenterol; 2009 Jun; 23(6):421-4. PubMed ID: 19543572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multidimensional education program at substance dependence treatment centers improves patient knowledge and hepatitis C care.
    Marinho RT; Costa A; Pires T; Raposo H; Vasconcelos C; Polónia C; Borges J; Soares M; Vilar G; Nogueira AM;
    BMC Infect Dis; 2016 Oct; 16(1):565. PubMed ID: 27733137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.
    Treloar C; Hull P; Dore GJ; Grebely J
    Drug Alcohol Rev; 2012 Nov; 31(7):918-24. PubMed ID: 22612899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients.
    Charlebois A; Lee L; Cooper E; Mason K; Powis J
    J Viral Hepat; 2012 Dec; 19(12):836-42. PubMed ID: 23121361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.